Difluprednate 0.05% versus Prednisolone Acetate Post-Phacoemulsification for Inflammation and Pain: An Efficacy and Safety Clinical Trial

Código QR

Difluprednate 0.05% versus Prednisolone Acetate Post-Phacoemulsification for Inflammation and Pain: An Efficacy and Safety Clinical Trial

Claudia Palacio-Pastrana,1 Eduardo Chávez-Mondragón,2 Abraham Soto-Gómez,3 Rubén Suárez-Velasco,4 Miguel Montes-Salcedo,5 Lourdes Fernández de Ortega,6 Linda Nasser-Nasser,7 Leopoldo Baiza-Durán,8 Oscar Olvera-Monta&nti...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Palacio-Pastrana C, Chávez-Mondragón E, Soto-Gómez A, Suárez-Velasco R, Montes-Salcedo M, Fernández de Ortega L, Nasser-Nasser L, Baiza-Durán L, Olvera-Montaño O, Muñoz-Villegas P
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	difluprednate dose-reduction cataract surgery ophthalmic corticosteroids Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/e872e9bd32b943f6bf9478ac1b9374eb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®)
por: Katelin Quantz, et al.
Publicado: (2021)

Topical Difluprednate for Early Corneal Graft Rejection After Penetrating Keratoplasty
por: Said OM, et al.
Publicado: (2020)

A retrospective analysis of intraocular pressure changes after cataract surgery with the use of prednisolone acetate 1% versus difluprednate 0.05%
por: Kusne Y, et al.
Publicado: (2016)

Dose uniformity of topical corticosteroid preparations: difluprednate ophthalmic emulsion 0.05% versus branded and generic prednisolone acetate ophthalmic suspension 1%
por: William Stringer, et al.
Publicado: (2010)

Halobetasol propionate lotion 0.05% in patients 12 to 16 years 11 months of age with plaque psoriasis: Results of an open-label study evaluating adrenal suppression potentialCapsule Summary
por: Vivian Laquer, MD, et al.
Publicado: (2022)

Initial Treatment Response in Ocular Myasthenia Gravis: A Comparison Between Low and Moderate Doses of Prednisolone
por: Threetong T, et al.
Publicado: (2020)

Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting
por: Hiroyuki Goto, et al.
Publicado: (2021)

Difluprednate ophthalmic emulsion 0.05% (Durezol&reg;) administered two times daily for managing ocular inflammation and pain following cataract surgery
por: Stephen Smith, et al.
Publicado: (2010)

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
por: White DE, et al.
Publicado: (2019)

Dose uniformity of loteprednol etabonate ophthalmic gel (0.5%) compared with branded and generic prednisolone acetate ophthalmic suspension (1%)
por: Marlowe ZT, et al.
Publicado: (2013)

Customized anterior segment photoacoustic imaging for ophthalmic burn evaluation in vivo
por: Huangxuan Zhao, et al.
Publicado: (2021)

QUALITY OF LIFE EVALUATION FOR HIV-INFECTED PATIENTS WITH EYE DISEASES
por: I. I. Ivanova, et al.
Publicado: (2016)

The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
por: Turan-Vural E, et al.
Publicado: (2011)

Review of optometry
Publicado: (1998)

Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study
por: Massin P, et al.
Publicado: (2016)

Estrategia terapéutica para prevenir la remodelación de las vías aéreas
por: Carrasco C.,Edgardo
Publicado: (2004)

Intra-Arterial Tissue Plasminogen Activator for Central Retinal Artery Occlusion
por: Sobol EK, et al.
Publicado: (2021)

Neurofibromatosis: an update of ophthalmic characteristics and applications of optical coherence tomography
por: Abdolrahimzadeh B, et al.
Publicado: (2016)

Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
por: Kanamoto T, et al.
Publicado: (2012)

Factores asociados a respuesta favorable de tratamiento corticoidal en pacientes con polirradiculoneuropatía desmielinizante inflamatoria crónica
por: Fuentealba S.,Mario, et al.
Publicado: (2020)

Ocular anti-inflammatory activity of prednisolone acetate loaded chitosan-deoxycholate self-assembled nanoparticles
por: Hanafy AF, et al.
Publicado: (2019)

A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole
por: Ahmed TA, et al.
Publicado: (2017)

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
por: Inoue K, et al.
Publicado: (2012)

Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET
por: Kahnert K, et al.
Publicado: (2021)

Tratamiento no antimicrobiano de infecciones
por: Pérez G,Jorge
Publicado: (2003)

Distinct domain switching in Nd0.05Ce0.95CoIn5 at low and high fields
por: D. G. Mazzone, et al.
Publicado: (2018)

Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
por: Mizoguchi T, et al.
Publicado: (2017)

Difficult indirect carotid-cavernous fistulas – alternative techniques to gaining access for treatment
por: El-Hindy N, et al.
Publicado: (2014)

The Impact of Three Waves of the COVID-19 Pandemic on the Characteristics of Primary Rhegmatogenous Retinal Detachments at a Tertiary Referral Centre
por: Dmuchowska D, et al.
Publicado: (2021)

Critical Aspects in the Preparation of Extemporaneous Flecainide Acetate Oral Solution for Paediatrics
por: Antonella Casiraghi, et al.
Publicado: (2021)

Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma
por: Andrew Li, et al.
Publicado: (2021)

Size-Dependent Cytotoxicity and Reactive Oxygen Species of Cerium Oxide Nanoparticles in Human Retinal Pigment Epithelia Cells
por: Ma Y, et al.
Publicado: (2021)

Uso antenatal de corticosteóide e evolução clínica de recém-nascidos pré-termo
Publicado: (2006)

The Bayes Factor, a Suitable Complement beyond Values of p<0.05 in Nursing Research and Education
por: Cristian Antony Ramos-Vera
Publicado: (2021)

Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
por: Deveney T, et al.
Publicado: (2018)

Can the Three-Dimensional Heads-Up Display Improve Ergonomics, Surgical Performance, and Ophthalmology Training Compared to Conventional Microscopy?
por: Bin Helayel H, et al.
Publicado: (2021)

Dermatologists’ Knowledge and Attitudes Toward Dry Eye Disease, Refractive Surgery, and Contact Lenses When Prescribing Isotretinoin in Saudi Arabia
por: Basheikh A, et al.
Publicado: (2020)

Microbial Contamination of Extended Use Ophthalmic Drops in Ophthalmology Clinic
por: Chua SW, et al.
Publicado: (2021)

Oxidative stress and its downstream signaling in aging eyes
por: Pinazo-Durán MD, et al.
Publicado: (2014)

Addition Of D-Sorbitol Improves The Usability Of Ophthalmic Viscosurgical Devices
por: Watanabe I, et al.
Publicado: (2019)